Search
By David Schultz on www.slate.com / medical
2 min read
With a Name Like Xalkori
New drug names aren’t just bizarre—they’re dangerous. What would Don Draper make of Xalkori? Pfizer’s lung cancer drug, released in 2011,...
By Rebecca Boyle, Popular science, april 2013
3 min read
How does a drug get its name?
Street names aside, who comes up with crazy non-words like Zyrtec, Tenofovir and Xeljanz? Say it with me: Xeljanz. OK, at least try and...
Anthony J Cordato of Cordato Partners, Australia
5 min read
How the Nurofen Specific Pain Range marketing strategy was undone as misleading by the Australian AC
It was a brilliant marketing strategy … instead of marketing the fast-acting Nurofen for pain relief as one product effective for a range...
By Bronwen Morgan
1 min read
Pharma product launch optimisation tool
Vivisum has launched Brand Builder, a solution that provides strategic market insight for pharmaceutical brands. Brand Builder combines...
by FiercePharma editor
3 min read
As biosims win nods in Europe and India, debate over naming rights heats up
From www.fiercepharma.com Drugmakers, biotechs and their generic rivals are squabbling over the names that will be assigned to...
Franki Webb in iPPro interviews Ira Levy
5 min read
The FDA way
Ira Levy of Goodwin Procter discusses the FDA regulation for drug names and how companies can reduce their chances of rejection. What is...
From www.nytimes.com
5 min read
FDA Approves Zarxio, First Biosimilar Drug
The approval paves the way for alternatives to an entire class of complex and costly drugs to go on the market. Most brand-name drugs...